TG Therapeutics secures $250M debt financing

Blue Owl Capital (NYSE:OWL) and HealthCare Royalty have entered into a $250M term loan facility with biopharmaceutical company TG Therapeutics (NASDAQ:TGTX).

The companies funded the loan at closing, with each party offering $125M. This initial term loan will mature on August 2, 2029. An additional